Autotransfusion Systems Market
Autotransfusion Systems Market Analysis by Products and Accessories for Cardiovascular Surgeries, Orthopedic Surgeries, and Others from 2023 to 2033
Analysis of Autotransfusion Systems Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Autotransfusion Systems Market Outlook (2023 to 2033)
The global autotransfusion systems market is valued at US$ 315.4 million in 2023 and is expected to expand at 4% CAGR to reach US$ 466.8 million by the end of 2033.
An autotransfusion is a procedure in which a patient receives a transfusion of their blood rather than stored allogenic (separate-donor) blood. The patient's blood is collected and reinfused using autotransfusion devices. These systems are crucial to cell salvage procedures, which allow autologous blood transfusions to lower the risk of infections brought on by allogeneic blood transfusions.
Autotransfusion tools are used in invasive procedures such as heart surgeries, orthopaedic surgeries, neurological surgeries, obstetrical and gynaecological surgeries, etc. Systems can be divided into three categories according to their usability: postoperative systems, intraoperative systems, and dual-mode systems. The rising cases related to surgeries worldwide are boosting the sales of autotransfusion systems.
- For instance, around 18 million deaths take place each year due to cardiovascular disorders worldwide, according to WHO.
Such statistics can help to understand the rate of surgeries taking place worldwide. Global demand for autotransfusion systems is also increasing due to the rapidly rising rate of the ageing population, the growing prevalence of chronic disorders, and the need for advanced blood management systems.
Autotransfusion products & accessories are two segments of the market. Global demand for autotransfusion products is predicted to progress at a CAGR of 4.5% during the next 10 years. Due to their effectiveness in blood transfusion, autotransfusion products are becoming more and more popular in both developed and developing nations.
Furthermore, it is anticipated that greater connectivity, transfusion report generations, technological developments for better clinical results, and improved flexibility are fuelling sales growth. The growing rate of blood transfusion and increasing demand for proper blood management are boosting the sales of autotransfusion accessories. The demand for autotransfusion accessories is expected to increase at a CAGR of 3% during the forecast period.
Report Attributes |
Details |
|
Autotransfusion Systems Market Size (2023E) |
US$ 315.4 Million |
|
Forecasted Market Value (2033F) |
US$ 466.8 Million |
|
Global Market Growth Rate (2023 to 2033) |
4% CAGR |
|
China Market Growth Rate (2023 to 2033) |
4% CAGR |
|
Japan Market Growth Rate (2023 to 2033) |
4% CAGR |
|
Germany Market Growth Rate (2023 to 2033) |
4% CAGR |
|
Canada Market Growth Rate (2023 to 2033) |
3.5% CAGR |
|
Key Companies Profiled |
|
What is Expected to Aid Providers of Autotransfusion Systems Gain Market Share?
“Strong Shift towards Autologous Blood Transfusion”
Allogeneic blood infusions are quite likely to have negative effects such as increased mortality, tumour recurrence, post-operative infections, acute lung injuries, and post-operative cardiac failures. Examples include the prevalence of transfusion-associated circulatory overload (TACO) and transfusion-related acute lung injury (TRALI), which are estimated to be 1% and 0.1% of transfusion cases in the United States, respectively, following numerous patient-based research.
As a result, shifting preference in favour of cell salvage can significantly minimize the need for allogeneic blood transfusion, hence reducing the likelihood of unfavourable side effects, which subsequently is boosting the autotransfusion system demand.
“Rapidly Increasing Number of Surgeries”
Blood transfusions and intra and postoperative cell salvage are crucial components of blood conservation throughout every surgical treatment. Growing cases of high-bleeding procedures and the emphasis on minimizing problems from allogeneic transfusions are also anticipated to fuel the growth of the autotransfusion systems market over the forecast period.
- For instance, the American Academy of Orthopaedic Surgeons (AAOS) and the Agency for Healthcare Research and Quality (AHRQ) estimate that every year in the United States, approximately 700,000 knee replacements and about 450,000 hip replacements are carried out.
- The University of Alabama revealed in a 2021 article that 320,000 coronary artery bypass grafting surgeries were carried out in the United States in the year 2020.
- The World Health Organization (WHO) 2022 study states that worldwide, crashes and traffic accidents result in 1.3 million fatalities per year. An additional 20 to 50 million people sustain non-fatal injuries, and many of them suffered physical impairment.
One of the main causes of disabilities and mortality worldwide is traffic accidents. Also, due to the increasing trend of physical activities, children and adults are more likely to experience sports-related injuries. The growing awareness of intraoperative and postoperative blood salvage is generating new opportunities in the market for autotransfusion systems, says Fact.MR, a market research and competitive intelligence provider.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Factors are Hampering the Sales of Autotransfusion Products?
“Surging Demand for Minimally-invasive Surgeries and Increasing Use of Hemostatic Devices”
Patients are gradually turning away from invasive procedures in favour of minimally-invasive ones. During the projection period, the use of minimally-invasive surgical procedures is anticipated to rise due to several variables, including shorter hospital stays, lower costs, quicker patient recoveries, and more patient comfort. As less blood is lost during minimally-invasive surgeries, it is hoped that the increasing use of less-invasive surgery would eventually lessen the need for blood conservation or allogeneic transfer.
- For instance, the German Heart Surgery Report estimates that in 2020, almost 55.2% of isolated mitral valve surgeries were carried out by minimally-invasive access, which represents a significant increase from the year prior.
The adoption of hemostatic products to stop significant blood loss is also anticipated to impede the sales of products for autotransfusion systems.
Country-wise Analysis
Why is the United States Considered a Profitable Market for Autotransfusion System Manufacturers?
“Presence of Key Market Players and Advanced Healthcare Systems”
The United States is expected to dominate the North American autotransfusion systems market, throughout the forecast period. The presence of major autotransfusion system companies, the high volume of surgeries performed in the country, and the well-established healthcare infrastructure are some of the aspects driving the demand for autotransfusion products.
Furthermore, favourable government programs and knowledge of autotransfusion due to a scarcity of allogenic blood in the nation are some of the factors anticipated to spur sales growth. A sophisticated healthcare sector and benevolent healthcare policies in the United States are supporting sales growth.
- The American National Red Cross estimates that 36,000 units of red blood cells are required in the country per day.
According to statistics, this country's rising disposable income and growing blood donation deficiency both contribute to the United States autotransfusion systems market growth.
How is Demand for Autotransfusion Systems Evolving in Germany?
“Increasing Surgical Cases Related to Trauma & Accidents”
Favourable health reimbursement policies, rising cases related to trauma and accident surgeries, and robust advancement in the medical sector are expected to increase the sales of autotransfusion devices in Germany. The rising government funding for healthcare R&D is also expected to support sales growth.
Growing accident and trauma cases, increasing rate of sports-related injuries, and rising ageing population who are more prone to experience orthopedic surgeries are fuelling the demand for autotransfusion systems in the nation. Sales of autotransfusion systems in Germany are predicted to evolve at a CAGR of 4% during the forecast period.
What is Supporting the Development of Autotransfusion Systems in South Korea?
“Growing Awareness of and Advancements in Blood Management Systems”
Rapidly developing blood management systems in South Korea are expected to boost the sales of autotransfusion systems. The demand for blood surpasses the supply despite Korea having a greater blood donation rate than high-income countries (5.04% vs. 3.15%), according to the WHO. This is brought on by the ageing and expanding recipient population, the declining birth rate, and the scarcity of young donors.
Blood transfusion is a vital aspect of any surgery to save lives. Thus, the increasing awareness for blood management, rising government initiatives for blood donation and management, and growing R&D activities on blood transfusion are boosting the demand for autotransfusion systems.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Analysis
For Which Disorders are Autotransfusion Systems Widely Used?
“Rising Prevalence of Cardiovascular Disorders”
Based on application, the autotransfusion systems are segmented into cardiovascular surgeries, orthopedic surgeries, obstetrics & gynecological surgeries, and neurological surgeries. It is predicted that the demand for autotransfusion devices from cardiovascular surgeries will increase at a rapid pace during the forecast period, due to the rising prevalence of cardiovascular disorders worldwide.
Rising cases related to heart disorders such as coronary artery bypass grafting (CABG), implantable cardioverter-defibrillator (ICD) & pacemaker implantations, heart transplantations, and valve replacement are increasing the chances of surgeries, which subsequently increases the demand for autotransfusion systems. Also, the rising prevalence of orthopedic surgeries is expected to increase demand for autotransfusion devices at a high pace during the forecast period.
Why Do Hospitals Account for High Demand for Autotransfusion Systems?
“Hospitals First Preference of Patients to Get Advanced & Effective Treatment”
Demand for autotransfusion systems from hospitals is expected to evolve at a rapid pace from 2023 to 2033. Rising cases related to surgeries, increasing prevalence of chronic disorders resulting in operations, and advancements in technologies and infrastructure are attracting patients to visit hospitals to get advanced treatment procedures.
Thus, the high intake of patients in hospitals is boosting the sales of autotransfusion devices. However, it is projected that in the coming years, specialty clinics will increasingly use intraoperative and postoperative cell salvage, particularly in developed regions, which would increase demand for autotransfusion systems.
Competitive Landscape
Some of the key players in the autotransfusion systems market are Atrium Medical Corporation (A Part of Getinge Group), LivaNova, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd, Haemonetics, Braile Biomédica, and Fresenius Medical Care AG & Co. KGaA.
Several autotransfusion system providers are adopting various marketing strategies such as collaborations, partnerships, local supply, improving product standards, and more to earn more profits.
- In the autotransfusion systems market, LivaNova has a dominant position. The cardiovascular product section of LivaNova provides advanced autotransfusion systems. Due to its expertise and dedication to the study of novel solutions, the company is regarded as a global leader in autotransfusion. Since 2010, doctors have received support from LivaNova's most cutting-edge, intuitive, and potent ATS system, XTRA, which combines cutting-edge technological features with user-friendliness and potent performance. Over a million patients have benefited from XTRA, which has lowered the hazards of allogeneic transfusion and shortened hospital stays.
- One of the top brands in the autotransfusion systems industry is Fresenius. The company's Fresenius Kabi subsidiary provides a robust line of autotransfusion devices. For recycling blood intra and post or during cardiac, orthopedic, or vascular surgeries, Fresenius Kabi developed CATSmart, a novel continuous red cell separation technique based on continuous flow technology. The continuous flow technique used by CATSmart, the only autotransfusion device on the market, ensures quick access to red blood cells (RBCs) at any time with consistent quality.
- Haemonetics has established a strong position for itself in the autotransfusion systems market. The company offers a wide range of products for whole blood cells, plasma, and blood. During medium to high blood loss procedures, such as cardiac, orthopedic, trauma, transplant, vascular, and OBGYN surgeries, hospitals can recover and distribute back a patient's high-quality blood with the use of the company's Cell Saver Elite device.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Segments of Autotransfusion Systems Industry Research
-
By Type :
- Autotransfusion Products
- Autotransfusion Accessories
-
By Application :
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Obstetrics & Gynecological Surgeries
- Neurological Surgeries
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Global Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2022 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Type Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Autotransfusion Systems 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033 5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022 5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Type, 2018 to 2022 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Type, 2023 to 2033 6.3.1. Autotransfusion Products 6.3.2. Autotransfusion Accessories 6.4. Market Attractiveness Analysis By Type 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Application 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Application , 2018 to 2022 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2023 to 2033 7.3.1. Cardiovascular Surgeries 7.3.2. Orthopedic Surgeries 7.3.3. Obstetrics & Gynecological Surgeries 7.3.4. Neurological Surgeries 7.4. Market Attractiveness Analysis By Application 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Ambulatory Surgical Centers 8.3.3. Specialty Clinics 8.4. Market Attractiveness Analysis By End User 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022 9.3. Current and Future Market Value (US$ Mn)Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 10.3.1. By Country 10.3.1.1. United States 10.3.1.2. Canada 10.3.2. By Type 10.3.3. By Application 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Type 10.4.3. By Application 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 11.3. Current and Future Market Value (US$ Mn)Analysis and Forecast By Region, 2023 to 2033 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Type 11.3.3. By Application 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Type 11.4.3. By Application 11.4.4. By End User 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 12.3. Current and Future Market Value (US$ Mn)Analysis and Forecast By Region, 2023 to 2033 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. United Kingdom 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Type 12.3.3. By Application 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Type 12.4.3. By Application 12.4.4. By End User 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 13.3. Current and Future Market Value (US$ Mn)Analysis and Forecast By Region, 2023 to 2033 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Type 13.3.3. By Application 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Type 13.4.3. By Application 13.4.4. By End User 14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 14.3. Current and Future Market Value (US$ Mn)Analysis and Forecast By Region, 2023 to 2033 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Type 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Type 14.4.3. By Application 14.4.4. By End User 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 15.3. Current and Future Market Value (US$ Mn)Analysis and Forecast By Region, 2023 to 2033 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Type 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Type 15.4.3. By Application 15.4.4. By End User 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. Atrium Medical Corporation (A Part of Getinge Group) 17.3.1.1. Company Overview 17.3.1.2. Type overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. Becton, Dickinson and Company 17.3.2.1. Company Overview 17.3.2.2. Type overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Beijing ZKSK Technology Co., Ltd. 17.3.3.1. Company Overview 17.3.3.2. Type overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Braile Biomédica 17.3.4.1. Company Overview 17.3.4.2. Type overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Fresenius Medical Care AG & Co. KGaA 17.3.5.1. Company Overview 17.3.5.2. Type overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Gen World Medical Devices 17.3.6.1. Company Overview 17.3.6.2. Type overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Haemonetics Corporation 17.3.7.1. Company Overview 17.3.7.2. Type overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. Livanova PLC 17.3.8.1. Company Overview 17.3.8.2. Type overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Medtronic PLC 17.3.9.1. Company Overview 17.3.9.2. Type overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. Redax 17.3.10.1. Company Overview 17.3.10.2. Type overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 2: Global Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 4: Global Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 5: Global Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 17: North America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 2: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 3: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 4: Global Market Incremental $ Opportunity, 2023 to 2033
Figure 5: Global Market Share and BPS Analysis by Type, 2023 & 2033
Figure 6: Global Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 7: Global Market Attractiveness Analysis by Type, 2023 to 2033
Figure 8: Global Market Share and BPS Analysis by Application, 2023 & 2033
Figure 9: Global Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis by Application, 2023 to 2033
Figure 11: Global Market Share and BPS Analysis by End User, 2023 & 2033
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis by End User, 2023 to 2033
Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033
Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033
Figure 21: North America Market Share Analysis by Country, 2023 & 2033
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 24: North America Market Share and BPS Analysis by Type, 2023 & 2033
Figure 25: North America Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 26: North America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 27: North America Market Share and BPS Analysis by Application, 2023 & 2033
Figure 28: North America Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 30: North America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033
Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 40: Latin America Market Share and BPS Analysis by Type, 2023 & 2033
Figure 41: Latin America Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 42: Latin America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 43: Latin America Market Share and BPS Analysis by Application, 2023 & 2033
Figure 44: Latin America Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 45: Latin America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 46: Latin America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 48: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033
Figure 53: Europe Market Share Analysis by Country, 2023 & 2033
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: Europe Market Share and BPS Analysis by Type, 2023 & 2033
Figure 57: Europe Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 58: Europe Market Attractiveness Analysis by Type, 2023 to 2033
Figure 59: Europe Market Share and BPS Analysis by Application, 2023 & 2033
Figure 60: Europe Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 61: Europe Market Attractiveness Analysis by Application, 2023 to 2033
Figure 62: Europe Market Share and BPS Analysis by End User, 2023 & 2033
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 64: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033
Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 72: East Asia Market Share and BPS Analysis by Type, 2023 & 2033
Figure 73: East Asia Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 74: East Asia Market Attractiveness Analysis by Type, 2023 to 2033
Figure 75: East Asia Market Share and BPS Analysis by Application, 2023 & 2033
Figure 76: East Asia Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 77: East Asia Market Attractiveness Analysis by Application, 2023 to 2033
Figure 78: East Asia Market Share and BPS Analysis by End User, 2023 & 2033
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 80: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Type, 2023 & 2033
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Type, 2023 to 2033
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Application, 2023 & 2033
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Application, 2023 to 2033
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2023 & 2033
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033
Figure 101: MEA Market Share Analysis by Country, 2023 & 2033
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 104: MEA Market Share and BPS Analysis by Type, 2023 & 2033
Figure 105: MEA Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 106: MEA Market Attractiveness Analysis by Type, 2023 to 2033
Figure 107: MEA Market Share and BPS Analysis by Application, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 109: MEA Market Attractiveness Analysis by Application, 2023 to 2033
Figure 110: MEA Market Share and BPS Analysis by End User, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 112: MEA Market Attractiveness Analysis by End User, 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the value of the autotransfusion systems market in 2023?
The market for autotransfusion systems is valued at US$ 315.4 million in 2023.
What is the projected market value of autotransfusion systems by 2033?
Global demand for autotransfusion systems is expected to reach US$ 466.8 million by 2033.
What is the estimated CAGR of the autotransfusion systems market?
Worldwide sales of autotransfusion systems are expected to evolve at a CAGR of 4% during the projected period.
Which are the key markets for autotransfusion system providers?
The United States, Germany, and South Korea are profitable markets for autotransfusion system suppliers.
Who are the top 3 autotransfusion system companies?
Fresenius, Haemonetics, and LivaNova are leading producers of autotransfusion systems.
Autotransfusion Systems Market